What is Wilke Resources?
Wilke Resources, established in 1997, has carved a niche by providing innovative, science-based ingredients to the Dietary Supplement market. Initially focusing on Glucosamine Hydrochloride, Chondroitin Sulfate, and Creatine Monohydrate, the company has evolved to pioneer products such as Chitosan, D-Mannose, and ImmunoLin for applications in weight loss, urinary tract support, and immune support. Their forward-thinking approach is evident in their current development of Nebraska Cultures' Probiotics for gut health, specialty wound-healing chitosan for pets, marine-algae extracts like Seanol® for antioxidant benefits, and unique plant extracts such as GlucodOX for maintaining healthy blood glucose and cholesterol levels. Wilke Resources is dedicated to market development of science-backed ingredients, positioning itself as a provider of "Ingredients with a Difference."
How much funding has Wilke Resources raised?
Wilke Resources has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
What's next for Wilke Resources?
With the recent infusion of substantial expansion capital, Wilke Resources is poised for significant advancements. This strategic backing is expected to fuel further research and development into novel ingredients, enhance manufacturing capabilities, and broaden market reach. The company's trajectory suggests a focus on scaling its operations to meet growing demand for scientifically validated health and wellness solutions. Future initiatives will likely involve expanding their portfolio of specialty ingredients and strengthening partnerships within the global dietary supplement industry, reinforcing their position as an innovator in ingredient science.
See full Wilke Resources company page
